HHS starts layoffs of thousands of workers across its agencies
| | | | | | | | | | | | | | | | | | | | | |

HHS starts layoffs of thousands of workers across its agencies

On Apr. 1, 2025, layoff notices began arriving for thousands of employees of the sprawling U.S. Department of…

Alnylam Announces FDA Approval of AMVUTTRA® (vutrisiran), the First RNAi Therapeutic to Reduce Cardiovascular Death, Hospitalizations and Urgent Heart Failure Visits in Adults with ATTR Amyloidosis
| | |

Alnylam Announces FDA Approval of AMVUTTRA® (vutrisiran), the First RNAi Therapeutic to Reduce Cardiovascular Death, Hospitalizations and Urgent Heart Failure Visits in Adults with ATTR Amyloidosis

On Mar. 20, 2025, Alnylam Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) approval of the supplemental…